KELLY VAZQUEZ: Open Payments
NPI 1558144030 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 13 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $219 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Daiichi Sankyo Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $18 |
| KYOWA KIRIN, INC. | 1 | $14 |
Products named: Wegovy, JYNARQUE, INJECTAFER, SHINGRIX, PURIFIED CORTROPHIN GEL, TARPEYO, NUCALA, Veltassa.
Industry payments across NJ — which companies pay providers there.
